Zentalis Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Zentalis Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2018 to Q4 2023.
  • Zentalis Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $4.21M, a 1.93% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.21M -$83K -1.93% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $4.3M +$1.46M +51.6% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $2.84M +$903K +46.7% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $1.93M +$808K +71.9% Dec 31, 2020 10-K 2024-02-27
Q4 2019 $1.12M +$383K +51.7% Dec 31, 2019 10-K 2023-03-01
Q4 2018 $741K Dec 31, 2018 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.